Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

DYNAVAX TECHNOLOGIES CORP Director's Dealing 2023

Feb 21, 2023

32130_dirs_2023-02-21_d6fcf031-638b-4b68-badb-9a76865ae762.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DYNAVAX TECHNOLOGIES CORP (DVAX)
CIK: 0001029142
Period of Report: 2023-02-16

Reporting Person: MacDonald Kelly (SVP and CFO)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2023-02-16 Stock Option (Right to Buy) $11.12 A 100000 Acquired 2030-02-15 Common Stock (100000) Direct

Footnotes

F1: This option grant will vest over three (3) years with one third (1/3) of the shares subject to the option vesting twelve months after the grant date of February 16, 2023, and one thirty-sixth (1/36) of the shares
subject to the option vesting each month thereafter.